Cite
HARVARD Citation
Sands, B. et al. (n.d.). Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis. Inflammatory bowel diseases. 22 (3), p. . [Online].